What's new

Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised

Mar 28, 2025 - 15:44
 0
Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Ashok Leyland weighs closure of UK bus plant

Next Article

Defense One Radio, Ep. 176: Space Force Gen. Chance Saltzman

Related Posts

Procurement

Procurement

Feb 9, 2025  0

Summary of opinion: Porcilis ColiClos, 12/02/2025 Positive

Summary of opinion: Porcilis ColiClos, 12/02/2025 Positive

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025  0